Skip to main content
Premium Trial:

Request an Annual Quote

Barbara Alving, Gregory Critchfield

Barbara Alving has been named director of the National Center for Research Resources, part of the National Institutes of Health, the NIH said last week. 
Alving has served as acting director of the NCRR since 2005. She has worked as a public health officer for the US Food and Drug Administration on the NIH campus, has been the chief of the Department of Hematology and Vascular Biology at Walter Reed Army Institute of Research, was chief of the Department of Hematology and Oncology at the Washington Hospital Center, and was a director of the Division of Blood Diseases and Resources at the National Heart, Lung, and Blood Institute.
Alving also is a professor of medicine at the Uniformed Services University of Health Sciences, and has been a member of various committees on hematology

BioTrove has named Gregory Critchfield to its board of directors. Critchfield is president of Myriad Genetic Laboratories, a subsidiary of Myriad Genetics, a position he has held since 1998. Previously, he was senior vice president and chief medical and scientific officer of Quest Diagnostics.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.